Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center.
Cecilia CarpioGloria IacoboniGuillermo VillacampaEva CataláSabela BobilloAna PérezMoraima JiménezLaura SeguraMireia OlivéAnna FarriolsPau AbrisquetaDavid ValcarcelMaría Josep CarrerasFrancesc BoschPere BarbaPublished in: Leukemia & lymphoma (2021)